Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta Milan, Milan, Italy.
Cerebellum. 2024 Dec;23(6):2655-2670. doi: 10.1007/s12311-024-01733-7. Epub 2024 Aug 23.
Gillespie syndrome is a rare disorder caused by pathogenic variants in ITPR1 gene and characterized by the typical association of cerebellar ataxia, bilateral aniridia and intellectual disability. Since its first description in 1965, less than 100 patients have been reported and only 30 with a molecular confirmation.
We present two additional cases, both carrying a loss-of-function variant in the Gly2539 amino acid residue. We describe the clinical evolution of the patients, one of whom is now 17 years old, and discuss the updated phenotypic spectrum of the disorder.
The study gives an overview on the condition, allowing to confirm important data, such as an overall positive evolution of development (with some patient not presenting intellectual disability), a clinical stability of the neurological signs (regardless of a possible progression of cerebellar atrophy) and ocular aspects, and a low prevalence of general health comorbidities.
Data about development and the observation of middle-aged patients lend support to the view that Gillespie is to be considered a non-progressive cerebellar ataxia, making this concept a key point for both clinicians and therapists, and for the families.
Gillespie 综合征是一种罕见疾病,由 ITPR1 基因的致病性变异引起,其特征为小脑共济失调、双侧无虹膜和智力障碍的典型关联。自 1965 年首次描述以来,不到 100 例患者被报道,仅有 30 例具有分子确认。
我们介绍了另外两例病例,均携带 Gly2539 氨基酸残基的功能丧失变异。我们描述了患者的临床演变,其中一名患者现在已经 17 岁,并讨论了该疾病的更新表型谱。
该研究对该病症进行了概述,能够确认重要数据,例如发育的总体积极演变(一些患者没有智力障碍)、神经体征(无论小脑萎缩是否可能进展)和眼部方面的临床稳定性,以及一般健康合并症的低患病率。
关于发育的数据和对中年患者的观察支持 Gillespie 被认为是一种非进行性小脑共济失调的观点,这一概念是临床医生、治疗师和患者家庭的关键要点。